This post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
Australia has commenced rolling out COVID-19 booster shots to the population following new advice from Australian Technical Advisory Group on Immunisation (ATAGI). People who are aged 18 years and over will be offered a booster shot six months after receiving their second dose. Immunisation providers must check the Australian Immunisation Register (AIR) prior to administering any COVID-19 vaccines.
General practices who have stock and available bookings can commence providing boosters immediately. It is important that patients are aware the booster vaccination is not mandatory, however they are recommended to maintain immunity against COVID-19.
Boosters can be funded through the existing MBS items 93644, 93645, 93646, 93647, 93653, 93654, 93655 and 93656 are available to assess patients’ suitability for the second or subsequent dose of a COVID-19 vaccine dose.
From 1 November 2021, AstraZeneca COVISHIELD (ASTCOV), Sinopharm BBIBP-CorV (SINBBI), and Sinovac Coronavac (SINCOR) can now be recorded on the Australian Immunisation Register (AIR) if they were given on or after 1 October 2020. As with other COVID-19 vaccines administered overseas, records must include a Country of immunisation and a Batch Number to be recorded on the AIR.
A list of all vaccines currently able to be reported to AIR is available on the AIR vaccine code page. COVID-19 vaccines brands that can currently be recorded on the AIR:
On 1 November 2021, the TGA determined that Covaxin (manufactured by Bharat Biotech, India) and BBIBP-CorV (manufactured by Sinopharm, China) vaccines would be ‘recognised’ for the purpose of establishing a traveller’s vaccination status, along with the previously announced recognition of Coronavac (manufactured by Sinovac, China) and Covishield (manufactured by AstraZeneca, India).
Vaccines currently approved in Australia are:
AstraZeneca Vaxzevria
Pfizer/Biontech Comirnaty
Moderna Spikevax
Janssen-Cilag COVID Vaccine.
Vaccines recognised by TGA for travel into Australia:
Vaccine wastage refers to the loss of vaccine doses due to cold chain breaches, expired vials or other damage. The COVID-19 Vaccination Training gives details on how to dispose of vaccines:
Prior to disposal, the outer packaging (carton) should be defaced by striking through at least one panel of the carton with a sharpie or similar marker.
Any unused vaccine or waste material should be disposed of in accordance with local requirements in a clinical waste bin – vials must be disposed of in the provided sharps container to ensure they cannot be accessed.
wastage less than 5 vials should be reported in your Vaccine Stock Management Report; and
wastage of 5 vias and over should also be reported within the Wastage Report
wastage incidents (e.g. damaged vials or breach of cold chain requirements), of 5 vias and over must be reported immediately (within 2 hours of the incident occurring) by calling the VOC on 1800 318 208
GPs are now able to use the Specialist Assessment and Supervised Vaccination Clinics (SASVC) pathway to support their patients who have contraindications or precautions to vaccination or have experienced a serious Adverse Event Following an Immunisation (AEFI).
GPs and immunisation providers can email clinical questions to NSWISS, and NSWISS will provide advice to GPs who can then refer patients to an LHD in NSW that runs a Specialist Assessment and Supervised Vaccination Clinic (SASVC).
SASV clinics are now operational at Royal Prince Alfred, Liverpool, Campbelltown, Westmead Adults, John Hunter, Royal North Shore, Nepean and Wollongong Hospitals, with more being added.
Practices are encouraged to routinely review delegates in HPOS, including when staff leave an organisation. Visit the Services Australia website for instruction on how to edit and remove members delegations. All healthcare professionals with a HPOS account have access to My access history, which is an activity log showing a record of HPOS logins by users and their delegates for the previous 90 days. This is available via the main menu, My details, My access history:
The use of HPOS and associated programs is governed by laws and government policies, including the Australian Immunisation Register Act 2015, Privacy Act 1988 and HPOS Terms of Use.
Join the latest COVID-19 vaccine live stream update for GPs. The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout. Get involved by submitting questions and comments!
Speak up for the community: Do you know someone who could give great input about health needs and services? voices4health is the place where people living in central and eastern Sydney can contribute to decision-making about health needs and services in the area where they live. This is a place…
Stay alert for meningococcal symptoms NSW Health is urging health professionals to be on alert for symptoms of meningococcal disease and act immediately if they appear after the notification of three recent cases. So far this year, there have been 19 cases of meningococcal disease reported in NSW. The majority…
Nominate or Apply for the 2023 CESPHN Primary Health Awards: The annual Central and Eastern Sydney PHN (CESPHN) Health Awards recognises primary health care professionals and organisations that have provided exceptional service or an outstanding contribution to primary health care in the Central and Eastern region of Sydney during the…
Speak up for the Community: Are you interested in having a say about health needs and health services in your area? voices4health is the place where people living in central and eastern Sydney can contribute to decision-making about health needs and services in the area where they live. This is…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. General Manager First Nations Fashion + Design and Wiradjuri Woman living on Dharawal Country Emma Griggs (pictured below at the recent Australian Fashion Week 2023 at Carriageworks, Gadigal land), shared this: 1. What did…
Study Invitation for Parents of Children with Eczema: A research team at Western Sydney University is seeking parents for a study exploring their perspectives around topical steroid use for eczema management. Participants will be involved in a virtual (via Zoom or telephone) interview, which will take up to 1 hour….